
    
      In this national multicenter prospective open label trial, patients will be randomized 1:1 to
      experimental group (CMS group : Conus Medullaris Stimulation using pentapolar surgical lead,
      plus optimal medical management) or to control group (OMM group : optimal medical management
      alone) and followed for 12 months, in intention to treat.

      42 patients suffering of refractory pudendal neuralgia will be included. Optimal medical
      management will be prescribed by algologists in both groups according to patient pain relief.
    
  